S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns

Silk Road Medical (SILK) Stock Price, News & Analysis

$18.71
-0.32 (-1.68%)
(As of 03/27/2024 ET)
Today's Range
$18.47
$19.43
50-Day Range
$13.18
$19.03
52-Week Range
$6.08
$46.57
Volume
448,051 shs
Average Volume
972,747 shs
Market Capitalization
$732.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.18

Silk Road Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.18 Rating Score
Upside/​Downside
18.6% Upside
$22.18 Price Target
Short Interest
Healthy
9.50% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
1.51mentions of Silk Road Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$351,247 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.39) to ($1.29) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.02 out of 5 stars

Medical Sector

192nd out of 939 stocks

Surgical & Medical Instruments Industry

20th out of 96 stocks

SILK stock logo

About Silk Road Medical Stock (NASDAQ:SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock Price History

SILK Stock News Headlines

Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
SILK Oct 2024 25.000 call
SILK Jul 2024 25.000 call
Argus gets more bullish on Silk Road Medical, upgrades shares
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
Q4 2023 Silk Road Medical Inc Earnings Call
Silk Road Medical: Q4 Earnings Insights
Silk Road Medical Inc (SILK)
Silk Road Medical Q4 2023 Earnings Preview
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/27/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SILK
Employees
474
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.18
High Stock Price Target
$47.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+18.6%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Net Income
$-55,740,000.00
Pretax Margin
-31.47%

Debt

Sales & Book Value

Annual Sales
$177.13 million
Book Value
$3.88 per share

Miscellaneous

Free Float
36,550,000
Market Cap
$732.87 million
Optionable
Optionable
Beta
1.48
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

SILK Stock Analysis - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price target for 2024?

11 Wall Street analysts have issued 1 year price objectives for Silk Road Medical's stock. Their SILK share price targets range from $8.00 to $47.00. On average, they anticipate the company's share price to reach $22.18 in the next twelve months. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2024?

Silk Road Medical's stock was trading at $12.27 at the beginning of the year. Since then, SILK stock has increased by 52.5% and is now trading at $18.71.
View the best growth stocks for 2024 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) announced its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.07. The firm had revenue of $47.27 million for the quarter, compared to analysts' expectations of $42.23 million. Silk Road Medical had a negative trailing twelve-month return on equity of 36.38% and a negative net margin of 31.70%.

What ETFs hold Silk Road Medical's stock?

ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American Century Focused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI).

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $191.7 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

Silk Road Medical (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (10.40%), Vanguard Group Inc. (7.43%), Vanguard Group Inc. (7.38%), Goldman Sachs Group Inc. (5.16%), Goldman Sachs Group Inc. (5.16%) and Armistice Capital LLC (4.54%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin J Ballinger, Kevin M Klemz, Lucas W Buchanan, Marie L Jones, Richard Ruedy and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SILK) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners